The bridge between immediate treatment outcomes and long-term planning, where over-treatment is prevented and sustainable results are established
The Review Timeline: Four Windows of Assessment
Window 1: Safety Review (24 to 72 Hours)
Verify absence of serious adverse effects. Assess comfort, swelling pattern, bruising, vision changes, mouth movement, allergic response signs. Escalate to medical assessment if concerns exist.
Window 2: Early Response Assessment (2 to 3 Weeks)
Evaluate initial response, identify if correction/refinement is needed immediately. Swelling should be fully resolved. Communicate: ‘80% of settling is done; 20% will continue over next 4 to 6 weeks.’ Some asymmetry may still resolve as swelling clears.
Window 3: Stabilization Review (6 to 8 Weeks)
Confirm final result, establish baseline for long-term monitoring, recalibrate if needed. This is when high-quality photo baseline is taken. Recalibration decision: settled as intended, or asymmetry/under-correction emerged?
Window 4: Long-Term Monitoring (3 to 6 Months Onward)
Track stability over time, identify when re-treatment is appropriate, ensure cumulative effects are being managed. 3-month check-in and 6-month formal assessment with photo comparison.
Clinical Decision Criteria
At 2 to 3 Week Review
Criteria for ‘minor refinement needed’: Clear asymmetry not present at baseline, obvious under-correction in planned area, product displacement, patient expressing genuine concern (not just anxiety).
Criteria to defer to settling window: Subtle asymmetry may resolve, result close to intended but slightly underfilled (swelling may change appearance), patient anxious but objective result is appropriate.
Criteria to avoid refinement: Patient chasing perfection not correcting asymmetry, result objectively well-placed, swelling not fully resolved, patient comparing to different lighting/expression.
At 6 to 8 Week Review
Criteria for recalibration (micro-dose only): Clear asymmetry documented and unchanged from week 3, patient remains unsatisfied despite clinically appropriate result, specific structural imbalance identifiable, patient goal is refinement not major change.
Criteria to accept as-is: Result within planned parameters, any asymmetry minor or was baseline, patient satisfaction reasonable, objective assessment shows balanced improvement.
Criteria to discuss extended planning: Patient wants more significant change than micro-dose, current result is appropriate baseline, suggest staging over multiple sessions.
Patient Perception Reframing
Distinguish between legitimate correction needs and anxiety-driven requests. Reframing language for common anxieties:
‘What you’re experiencing is normal. Swelling creates unfamiliar appearance. Once it clears, you’ll have clearer sense of result.’
‘We’ll assess for refinement at your 6-week visit. That’s when result is fully settled.’
‘If you’re saying it looks worse than before, let’s clarify: is this because your face feels unfamiliar (swelling has changed how shadows and movement work) or because you think the actual result is over-treated? Unfamiliarity is temporary. Over-treatment we can address. Let’s assess at 6 weeks when swelling is gone and we can see the true result.’
This final reframing prevents panic-driven unnecessary refinement that accelerates over-treatment spirals.
Over-Treatment Prevention Through Recalibration
The Micro-Dose Spiral
Week 2: Patient feels underfilled, clinician adds 0.2mL. Year 5: Patient has received 3mL across same area. Prevention: Establish baseline volume. Don’t increase based on 2-week anxiety. Maintain that level, don’t allow drift.
Chasing Symmetry
Multiple micro-refinements trying to achieve perfect symmetry over 1 to 2 years. Prevention: Assess whether residual asymmetry is realistic to correct or inherent to facial structure. If inherent, discuss acceptance.
The Comparison Trap
Patient sees friend’s fuller cheeks, requests ‘like my friend has,’ clinician fears losing patient and adds product. Prevention: Base treatment plan on patient’s anatomy and goals, not comparison to others. Redirect at reviews.
Frequently asked questions
Why do I need a follow-up appointment at 6-8 weeks if I’m happy at 2 weeks?
The 6-week appointment establishes the final result baseline. Product may still be settling slightly. This is when we take definitive photos and document your baseline for all future comparisons.
What if I want refinement but my practitioner says to wait?
Waiting until 6 to 8 weeks is clinically appropriate. Product settling can change appearance. Assessing early may lead to unnecessary refinement. Patience here prevents over-treatment.
Can I always get a micro-dose refinement if needed?
Generally yes, if the need is clinically appropriate (asymmetry, under-correction). But refining something that’s clinically appropriate already (just unfamiliar to you psychologically) leads to over-treatment spiral.
How often should I have check-ins after 6 weeks?
3-month check-in for general wellbeing and to notice when product starts absorbing. 6-month formal assessment with photos to assess stability and plan next cycle. Then ongoing cadence based on your product absorption and goals.